| 2.17 0 (0%) | 05-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.54 | 1-year : | 2.97 |
| Resists | First : | 2.18 | Second : | 2.54 |
| Pivot price | 2.15 |
|||
| Supports | First : | 2.15 | Second : | 2.14 |
| MAs | MA(5) : | 2.16 |
MA(20) : | 2.15 |
| MA(100) : | 2.1 |
MA(250) : | 2.1 |
|
| MACD | MACD : | 0 |
Signal : | 0  |
| %K %D | K(14,3) : | 61.1 |
D(3) : | 61.1 |
| RSI | RSI(14): 63.9 | |||
| 52-week | High : | 2.71 | Low : | 1.63 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ FORA ] has closed below upper band by 6.6%. Bollinger Bands are 55.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.17 - 2.18 | 2.18 - 2.19 |
| Low: | 2.14 - 2.16 | 2.16 - 2.17 |
| Close: | 2.15 - 2.17 | 2.17 - 2.19 |
Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.
Wed, 22 Jul 2026
Forian Inc. Q1 2026 Earnings: Deep EPS Miss Highlights Unexpected Operational Challenges - Earnings Weakness Phase - dars.gov.et
Sun, 19 Jul 2026
Forian Inc. (FORA) Q1 2026 Earnings: EPS Misses Estimates Sharply Amid Revenue Absence - careplusvn.com
Fri, 15 May 2026
Forian Inc. Announces Completion of Tender Offer and Closing of Merger - Yahoo Finance
Thu, 23 Apr 2026
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Forian Inc. ("FORA"). - PR Newswire
Tue, 07 Apr 2026
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 31 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 51.7 (%) |
| Held by Institutions | 14.8 (%) |
| Shares Short | 54 (K) |
| Shares Short P.Month | 61 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.95 |
| Profit Margin | -17 % |
| Operating Margin | -51 % |
| Return on Assets (ttm) | -8.4 % |
| Return on Equity (ttm) | -18 % |
| Qtrly Rev. Growth | -3 % |
| Gross Profit (p.s.) | 0.45 |
| Sales Per Share | 0.96 |
| EBITDA (p.s.) | -0.19 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -24.12 |
| PEG Ratio | 0.8 |
| Price to Book value | 2.26 |
| Price to Sales | 2.25 |
| Price to Cash Flow | 35.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|